MEA Radioimmunoassay Market - Industry Trends and Forecast to 2030

Description

List of Tables

Middle East and Africa radioimmunoassay market is projected to register a substantial CAGR of 2.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (China, Japan, India, South Korea, Australia, Indonesia, Philippines, Thailand, Malaysia, Singapore, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Middle East and Africa radioimmunoassay market are:

Increase in the demand for error-free and accurate results of high throughput and automated procedures

Rise in the technological advancements

Strategic initiatives by market players

Increasing significance of research and development in medical science

Market Players:

The key market players in Middle East and Africa radioimmunoassay market are listed below:

PerkinElmer Inc.

Merck KGaA

EUROIMMUN Medizinische Labordiagnostika AG

Beckman Coulter, Inc.

Hidex Oy.

1 INTRODUCTION 65

1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67

2 MARKET SEGMENTATION 71

2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83

3 EXECUTIVE SUMMARY 84

4 PREMIUM INSIGHTS 87

4.1 PESTEL ANALYSIS 88
4.2 PORTYER'S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90

5 INDUSTRY INSIGHTS: 91

6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92

6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94

7 MARKET OVERVIEW 95

7.1 DRIVERS 97
- 7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
- 7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
- 7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
- 7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
- 7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
- 7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
- 7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
- 7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
- 7.4.1 LACK OF SKILLED PROFESSIONALS 103
- 7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103

8 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104

8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
- 8.2.1 KITS 109
- 8.2.2 BUFFER 109
  - 8.2.2.1 SOLUTION 109
  - 8.2.2.2 POWDER 109
- 8.2.3 STANDARD CONCENTRATES 110
- 8.2.4 PRECIPITATING REAGENTS 110
- 8.2.5 RADIOISOTOPES 110
  - 8.2.5.1 BETA EMITTERS 110
    - 8.2.5.1.1 TRITIUM 110
    - 8.2.5.1.2 CARBON-14 111
  - 8.2.5.2 GAMMA EMITTERS 111
    - 8.2.5.2.1 IODINE-125 111
    - 8.2.5.2.2 CHROMIUM-51 111
    - 8.2.5.2.3 COBALT-57 111
- 8.2.6 ANTIBODY/ANTISERUM 112
  - 8.2.6.1 POLYCLONAL 112
  - 8.2.6.2 MONOCLONAL 112
- 8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113

9 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION 114

9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
- 9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
- 9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
- 9.3.1 INFECTIOUS DISEASE TESTING 120
  - 9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
  - 9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
- 9.3.2 ALLERGY TESTING 121
  - 9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
- 9.3.3 ONCOLOGY TESTING 121
  - 9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.4 ENDOCRINE TESTING 122
  - 9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
  - 9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.5 TOXICOLOGY TESTING 123
  - 9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
  - 9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
- 9.3.6 AUTOIMMUNE DISEASE TESTING 123
  - 9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
  - 9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
- 9.3.7 OTHER DISEASE TESTING 124

10 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY END USER 125

10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132

11 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133

11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140

12 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY REGION 141

12.1 MIDDLE EAST AND AFRICA 142
- 12.1.1 SOUTH AFRICA 154
- 12.1.2 SAUDI ARABIA 161
- 12.1.3 UAE 168
- 12.1.4 EGYPT 176
- 12.1.5 ISRAEL 184
- 12.1.6 REST OF MIDDLE EAST AND AFRICA 192

13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 193

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 193

14 SWOT ANALYSIS 194

15 COMPANY PROFILE 195

15.1 PERKINELMER INC. 195
- 15.1.1 COMPANY SNAPSHOT 195
- 15.1.2 REVENUE ANALYSIS 195
- 15.1.3 COMPANY SHARE ANALYSIS 196
- 15.1.4 PRODUCT PORTFOLIO 196
- 15.1.4 RECENT DEVELOPMENT 197
15.2 MERCK KGAA 198
- 15.2.1 COMPANY SNAPSHOT 198
- 15.2.2 REVENUE ANALYSIS 198
- 15.2.3 COMPANY SHARE ANALYSIS 199
- 15.2.4 PRODUCT PORTFOLIO 199
- 15.2.5 RECENT DEVELOPMENTS 199
15.3 BECKMAN COULTER, INC. 201
- 15.3.1 COMPANY SNAPSHOT 201
- 15.3.2 COMPANY SHARE ANALYSIS 201
- 15.3.3 PRODUCT PORTFOLIO 201
- 15.3.4 RECENT DEVELOPMENT 202
15.4 ABCAM PLC 203
- 15.4.1 COMPANY SNAPSHOT 203
- 15.4.2 REVENUE ANALYSIS 203
- 15.4.3 COMPANY SHARE ANALYSIS 204
- 15.4.4 PRODUCT PORTFOLIO 204
- 15.4.5 RECENT DEVELOPMENT 204
15.5 TECAN TRADING AG 205
- 15.5.1 COMPANY SNAPSHOT 205
- 15.5.2 REVENUE ANALYSIS 205
- 15.5.3 COMPANY SHARE ANALYSIS 206
- 15.5.4 PRODUCT PORTFOLIO 206
- 15.5.5 RECENT DEVELOPMENT 207
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 208
- 15.6.1 COMPANY SNAPSHOT 208
- 15.6.2 PRODUCT PORTFOLIO 208
- 15.6.3 RECENT DEVELOPMENTS 208
15.7 DEMEDITEC DIAGNOSTICS GMBH 209
- 15.7.1 COMPANY SNAPSHOT 209
- 15.7.2 PRODUCT PORTFOLIO 209
- 15.7.3 RECENT DEVELOPMENTS 210
15.8 DIASOURCE 211
- 15.8.1 COMPANY SNAPSHOT 211
- 15.8.2 PRODUCT PORTFOLIO 211
- 15.8.3 RECENT DEVELOPMENT 211
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 212
- 15.9.1 COMPANY SNAPSHOT 212
- 15.9.2 PRODUCT PORTFOLIO 212
- 15.9.3 RECENT DEVELOPMENTS 212
15.10 HIDEX OY 214
- 15.10.1 COMPANY SNAPSHOT 214
- 15.10.2 PRODUCT PORTFOLIO 214
- 15.10.3 RECENT DEVELOPMENTS 214
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 215
- 15.11.1 COMPANY SNAPSHOT 215
- 15.11.2 PRODUCT PORTFOLIO 215
- 15.11.3 RECENT DEVELOPMENT 217
15.12 INSTITUTE OF ISOTOPES 218
- 15.12.1 COMPANY SNAPSHOT 218
- 15.12.2 PRODUCT PORTFOLIO 218
- 15.12.3 RECENT DEVELOPMENTS 219
15.13 KAMIYA BIOMEDICAL COMPANY 220
- 15.13.1 COMPANY SNAPSHOT 220
- 15.13.2 PRODUCT PORTFOLIO 220
- 15.13.3 RECENT DEVELOPMENTS 220
15.14 MP BIOMEDICALS 221
- 15.14.1 COMPANY SNAPSHOT 221
- 15.14.2 PRODUCT PORTFOLIO 221
- 15.14.3 RECENT DEVELOPMENTS 222
15.15 MYBIOSOURCE.COM. 223
- 15.15.1 COMPANY SNAPSHOT 223
- 15.15.2 PRODUCT PORTFOLIO 223
- 15.15.3 RECENT DEVELOPMENT 223

16 QUESTIONNAIRE 224

17 RELATED REPORTS 227

LIST OF TABLES

TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 51
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 56
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 57
TABLE 4 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
TABLE 5 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 66
TABLE 6 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 7 MIDDLE EAST & AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 8 MIDDLE EAST & AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
TABLE 9 MIDDLE EAST & AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
TABLE 10 MIDDLE EAST & AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 11 MIDDLE EAST & AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 12 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 75
TABLE 14 MIDDLE EAST & AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 15 MIDDLE EAST & AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 16 MIDDLE EAST & AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 17 MIDDLE EAST & AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 78
TABLE 18 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 78
TABLE 19 MIDDLE EAST & AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 79
TABLE 20 MIDDLE EAST & AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 79
TABLE 21 MIDDLE EAST & AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 80
TABLE 22 MIDDLE EAST & AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 81
TABLE 23 MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 81
TABLE 24 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 86
TABLE 25 MIDDLE EAST & AFRICA HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 26 MIDDLE EAST & AFRICA CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 27 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 28 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 29 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 30 MIDDLE EAST & AFRICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 31 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 94
TABLE 32 MIDDLE EAST & AFRICA DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 33 MIDDLE EAST & AFRICA ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 34 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 35 MIDDLE EAST & AFRICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 36 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 104
TABLE 37 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 38 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 39 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 105
TABLE 40 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 105
TABLE 41 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 42 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 106
TABLE 43 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 106
TABLE 44 MIDDLE EAST AND AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 45 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 46 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 106
TABLE 47 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 107
TABLE 48 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
TABLE 49 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 107
TABLE 50 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 107
TABLE 51 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
TABLE 52 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 108
TABLE 53 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 108
TABLE 54 MIDDLE EAST AND AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 108
TABLE 55 MIDDLE EAST AND AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 108
TABLE 56 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 108
TABLE 57 MIDDLE EAST AND AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 58 MIDDLE EAST AND AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 109
TABLE 59 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 60 MIDDLE EAST AND AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 61 MIDDLE EAST AND AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 62 MIDDLE EAST AND AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 63 MIDDLE EAST AND AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 110
TABLE 64 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 65 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 110
TABLE 66 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 111
TABLE 67 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 68 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 69 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 70 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 71 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 72 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 73 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 74 SOUTH AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 75 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 76 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 77 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 78 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 79 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 80 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 81 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 82 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 83 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 84 SOUTH AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 85 SOUTH AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 86 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 87 SOUTH AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 88 SOUTH AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 89 SOUTH AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 90 SOUTH AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 91 SOUTH AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 92 SOUTH AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 93 SOUTH AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 94 SOUTH AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 95 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 118
TABLE 96 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 97 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 98 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 99 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 100 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 101 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 102 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 103 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 104 SAUDI ARABIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 105 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 106 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 107 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 108 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 109 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 110 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 111 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 122
TABLE 112 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 113 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 114 SAUDI ARABIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 115 SAUDI ARABIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 116 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 117 SAUDI ARABIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 118 SAUDI ARABIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 119 SAUDI ARABIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 120 SAUDI ARABIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 121 SAUDI ARABIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 122 SAUDI ARABIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 123 SAUDI ARABIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 124
TABLE 124 SAUDI ARABIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 125 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 126 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 127 UAE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 128 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 129 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 126
TABLE 130 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 126

TABLE 131 UAE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 132 UAE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 127
TABLE 133 UAE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 127
TABLE 134 UAE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 135 UAE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 136 UAE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 137 UAE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 138 UAE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 139 UAE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 140 UAE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 141 UAE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 142 UAE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 143 UAE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 144 UAE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 145 UAE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 146 UAE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 147 UAE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 148 UAE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 149 UAE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 150 UAE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 151 UAE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 152 UAE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 153 UAE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 132
TABLE 154 UAE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 155 UAE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 133
TABLE 156 UAE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 157 EGYPT RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 158 EGYPT RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 159 EGYPT RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 134
TABLE 160 EGYPT RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 134
TABLE 161 EGYPT BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 162 EGYPT BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 135
TABLE 163 EGYPT BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 164 EGYPT RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 165 EGYPT BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 166 EGYPT BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 167 EGYPT BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 136
TABLE 168 EGYPT GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 169 EGYPT GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 170 EGYPT GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 136
TABLE 171 EGYPT ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
TABLE 172 EGYPT ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 137
TABLE 173 EGYPT ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 137
TABLE 174 EGYPT RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 137
TABLE 175 EGYPT RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 137
TABLE 176 EGYPT RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
TABLE 177 EGYPT SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 178 EGYPT CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
TABLE 179 EGYPT INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 180 EGYPT ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 181 EGYPT ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 182 EGYPT ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 183 EGYPT TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 140
TABLE 184 EGYPT AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 185 EGYPT RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 141
TABLE 186 EGYPT RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 141
TABLE 187 ISRAEL RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 188 ISRAEL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 189 ISRAEL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 142
TABLE 190 ISRAEL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 142
TABLE 191 ISRAEL BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 192 ISRAEL BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 143
TABLE 193 ISRAEL BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 143
TABLE 194 ISRAEL RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 195 ISRAEL BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 196 ISRAEL BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 144
TABLE 197 ISRAEL BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 144
TABLE 198 ISRAEL GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 199 ISRAEL GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 144
TABLE 200 ISRAEL GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 144
TABLE 201 ISRAEL ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 202 ISRAEL ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 145
TABLE 203 ISRAEL ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 145
TABLE 204 ISRAEL RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 145
TABLE 205 ISRAEL RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 145
TABLE 206 ISRAEL RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 207 ISRAEL SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 208 ISRAEL CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
TABLE 209 ISRAEL INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 210 ISRAEL ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 211 ISRAEL ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 212 ISRAEL ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 213 ISRAEL TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 148
TABLE 214 ISRAEL AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 215 ISRAEL RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 149
TABLE 216 ISRAEL RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 149
TABLE 217 REST OF MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: SEGMENTATION 28
FIGURE 2 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION 31
FIGURE 3 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: DROC ANALYSIS 32
FIGURE 4 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 33
FIGURE 5 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS 33
FIGURE 6 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS 35
FIGURE 7 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID 36
FIGURE 8 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID 38
FIGURE 9 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 10 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: SEGMENTATION 43
FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD 44
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET IN 2023 & 2030 44
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET 53
FIGURE 14 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022 62
FIGURE 15 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 63
FIGURE 16 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 63
FIGURE 17 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE 64
FIGURE 18 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022 72
FIGURE 19 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 73
FIGURE 20 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030) 73
FIGURE 21 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE 74
FIGURE 22 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY END USER, 2022 83
FIGURE 23 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION) 84
FIGURE 24 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030) 84
FIGURE 25 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE 85
FIGURE 26 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022 91
FIGURE 27 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 92
FIGURE 28 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 92
FIGURE 29 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 93
FIGURE 30 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 100
FIGURE 31 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 101
FIGURE 32 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 101
FIGURE 33 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 102
FIGURE 34 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 102
FIGURE 35 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 150